These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 11980163)
1. [A comparative study of anapriline and carvedilol effectiveness in patients with thyrotoxicosis in pre- and postoperative periods]. Sarukhanian OV; Torgomian TG; Sisakian AS Klin Med (Mosk); 2002; 80(3):58-61. PubMed ID: 11980163 [TBL] [Abstract][Full Text] [Related]
2. The effects of different beta-blockers on left-ventricular volume and function after primary coronary stenting in acute myocardial infarction. Lee SH; Yoon SB; Cho JR; Choi S; Jung JH; Lee N Angiology; 2008 Dec-2009 Jan; 59(6):676-81. PubMed ID: 18388053 [TBL] [Abstract][Full Text] [Related]
3. [Antioxidant and antiarrhythmic activity of carvedilol in patients with ischemic heart disease. Comparison with anaprilin]. Vasil'ev AP; Strel'tsova NN; Gorbunova TIu; Mal'tseva IA; Zykova EL Ter Arkh; 2001; 73(10):65-7. PubMed ID: 11763521 [TBL] [Abstract][Full Text] [Related]
4. Carvedilol may alleviate late cardiac remodelling following surgical ventricular restoration. Yoshikawa E; Marui A; Tsukashita M; Nishina T; Wang J; Muranaka H; Ikeda T; Komeda M Eur J Cardiothorac Surg; 2010 Feb; 37(2):362-7. PubMed ID: 19692266 [TBL] [Abstract][Full Text] [Related]
5. [Clinical and hemodynamic effects of anaprilin and carvedilol in patients with coronary heart disease]. Vasil'ev AP; Strel'tsova NN; Gorbunova TIu; Dubova TV Klin Med (Mosk); 2001; 79(12):13-6. PubMed ID: 11840802 [TBL] [Abstract][Full Text] [Related]
6. Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised study. Hobolth L; Bendtsen F; Hansen EF; Møller S Dig Liver Dis; 2014 Mar; 46(3):251-6. PubMed ID: 24290869 [TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness of carvedilol and propranolol on glycemic control and insulin resistance associated with L-thyroxin-induced hyperthyroidism--an experimental study. Bhatt P; Makwana D; Santani D; Goyal R Can J Physiol Pharmacol; 2007 May; 85(5):514-20. PubMed ID: 17632586 [TBL] [Abstract][Full Text] [Related]
8. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis. Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642 [TBL] [Abstract][Full Text] [Related]
9. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol. Reiberger T; Ulbrich G; Ferlitsch A; Payer BA; Schwabl P; Pinter M; Heinisch BB; Trauner M; Kramer L; Peck-Radosavljevic M; Gut; 2013 Nov; 62(11):1634-41. PubMed ID: 23250049 [TBL] [Abstract][Full Text] [Related]
10. Cardiovascular risk factors in hypertension: rationale and design of studies to investigate the effects of controlled-release carvedilol on regression of left ventricular hypertrophy and lipid profile. Bakris GL; Tarka EA; Waterhouse B; Goulding MR; Madan A; Anderson KM; St John Sutton M; Miller AB; Reichek N Am J Cardiol; 2006 Oct; 98(7A):46L-52L. PubMed ID: 17023232 [TBL] [Abstract][Full Text] [Related]
11. Carvedilol--A new nonselective beta blocker. Forrest E; Stanley A; Hayes P Hepatology; 2000 Mar; 31(3):809-11. PubMed ID: 10722317 [No Abstract] [Full Text] [Related]
12. The impact of carvedilol and metoprolol on serum lipid concentrations and symptoms in patients with hyperthyroidism. Ozbilen S; Eren MA; Turan MN; Sabuncu T Endocr Res; 2012; 37(3):117-23. PubMed ID: 22571552 [TBL] [Abstract][Full Text] [Related]
13. Effect of carvedilol on coronary flow reserve in patients with hypertensive left-ventricular hypertrophy. Xiaozhen H; Yun Z; Mei Z; Yu S Blood Press; 2010 Feb; 19(1):40-7. PubMed ID: 20001392 [TBL] [Abstract][Full Text] [Related]
14. Reduction of oxidative stress by carvedilol: role in maintenance of ischaemic myocardium viability. Cargnoni A; Ceconi C; Bernocchi P; Boraso A; Parrinello G; Curello S; Ferrari R Cardiovasc Res; 2000 Aug; 47(3):556-66. PubMed ID: 10963728 [TBL] [Abstract][Full Text] [Related]
16. Three-dimensional echocardiographic and magnetic resonance assessment of the effect of telmisartan compared with carvedilol on left ventricular mass a multicenter, randomized, longitudinal study. Galzerano D; Tammaro P; del Viscovo L; Lama D; Galzerano A; Breglio R; Tuccillo B; Paolisso G; Capogrosso P Am J Hypertens; 2005 Dec; 18(12 Pt 1):1563-9. PubMed ID: 16364826 [TBL] [Abstract][Full Text] [Related]
17. An advance in the treatment of portal hypertension? Wong F; Blendis L Gastroenterology; 2000 Apr; 118(4):802-3. PubMed ID: 10734033 [No Abstract] [Full Text] [Related]
18. Experimental diabetes and left ventricular hypertrophy: effects of beta-receptor blockade. Grimm D; Jabusch HC; Kossmehl P; Huber M; Fredersdorf S; Griese DP; Krämer BK; Kromer EP Cardiovasc Pathol; 2002; 11(4):229-37. PubMed ID: 12140129 [TBL] [Abstract][Full Text] [Related]
19. [Contribution of antioxidant properties of carvedilol in its effect on cardiac remodeling in patients with ischemic heart disease with incipient heart failure]. Vasil'ev AP; Strel'tsova NN; Gorbunova TIu Kardiologiia; 2003; 43(2):69-70. PubMed ID: 12913988 [No Abstract] [Full Text] [Related]
20. [Effect of carvedilol on parameters of myocardial perfusion in patients with left ventricular remodeling after myocardial infarction]. Kardiologiia; 2009; 49(2):66. PubMed ID: 19254220 [No Abstract] [Full Text] [Related] [Next] [New Search]